Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Recruiting · NCT06714838 · Registry updated 2024-12-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Recruiting | Phase 3 | 2024-12-04 | NCT06714838 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC) | 2 |
| Erasmus Medical Center | 271 |
| Stichting Treatmeds | 4 |
| UMC Utrecht | 140 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam UMC | Amsterdam | Netherlands | 6 |